Internal Medicine, Endocrinology, Diabetes, & Metabolism · Orlando, FL
NPI
1821259649
Since 2008
Specialty
Internal Medicine, Endocrinology, Diabetes, & Metabolism
Code 207RE0101X
Group practices
4
Medicare group memberships
Hospitals
4
Hospital affiliations
2415 N Orange Ave Ste 502
Orlando, FL, 32804
Phone (407) 303-2801
Groups this clinician bills Medicare through
Medicare paid, 2024
$55K
1,105 services
Medicare patients, 2024
390
Average age 73
Drug cost, 2024
$1.7M
2,928 prescriptions
Company payments, 2025
$274
From 3 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Parkash A Bakhtiani was code 99214 (office e&m - established), 393 times for 312 patients. In total Parkash A Bakhtiani billed 1,105 services in 26 codes, and Medicare paid $55K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2020-10-05.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 393 | 312 | $82.50 | $32K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 213 | 205 | $12.42 | $2,646 |
| 99204 Office E&M - New | Office | 63 | 63 | $114.24 | $7,197 |
| 95251 Test - Miscellaneous | Office | 56 | 44 | $23.80 | $1,333 |
| 83036 Blood Count | Office | 27 | 25 | $9.52 | $257 |
| 82962 Clinical Chemistry | Office | 22 | 20 | $3.21 | $70.62 |
| 10005 Other Organ Systems | Office | 21 | 21 | $79.50 | $1,670 |
By year: 2022 $71K for 889 services; 2023 $88K for 996 services; 2024 $55K for 1,105 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 83036 Blood Count | 27 | 25 | $9.52 | $257 |
| 82962 Clinical Chemistry | 22 | 20 | $3.21 | $70.62 |
Medicare prescription drug claims, 2024
In 2024, the drug Parkash A Bakhtiani prescribed most often to Medicare patients was Levothyroxine Sodium, with 386 prescriptions and refills. In total Parkash A Bakhtiani wrote 2,928 Medicare prescriptions that cost $1.7M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Levothyroxine Sodium Generic | 386 | 1,072 | 170 | $4,201 |
| Ozempic Semaglutide | 231 | 398 | 89 | $368K |
| Metformin Hcl Er Metformin Hcl | 212 | 626 | 110 | $2,158 |
| Mounjaro Tirzepatide | 143 | 178 | 39 | $185K |
| Jardiance Empagliflozin | 113 | 254 | 45 | $147K |
| Synthroid Levothyroxine Sodium | 98 | 277 | 43 | $11K |
| Metformin Hcl Generic | 91 | 264 | 50 | $661 |
| Lantus Solostar Insulin Glargine,hum.Rec.Anlog | 91 | 214 | 38 | $16K |
| Rosuvastatin Calcium Generic | 78 | 198 | 35 | $1,063 |
| Trulicity Dulaglutide | 62 | 107 | 27 | $104K |
| Atorvastatin Calcium Generic | 54 | 158 | 30 | $259 |
| Glipizide Generic | 43 | 106 | 20 | $367 |
| Novolog Flexpen Insulin Aspart | 41 | 75 | 20 | $11K |
| Farxiga Dapagliflozin Propanediol | 41 | 77 | 16 | $43K |
| Tresiba Flextouch U-100 Insulin Degludec | 40 | 94 | 22 | $30K |
Brand drugs: 1,625 claims; generic drugs: 1,136 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Parkash A Bakhtiani $274 ($274 in general payments such as food, travel and fees) from 3 companies. The largest payer was CeQur Corporation with $156.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.